{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:38:12Z","timestamp":1787020692557,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100004482","name":"Research Sector, Kuwait University","doi-asserted-by":"crossref","award":["MK01\/12"],"award-info":[{"award-number":["MK01\/12"]}],"id":[{"id":"10.13039\/501100004482","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12944-016-0273-9","type":"journal-article","created":{"date-parts":[[2016,6,10]],"date-time":"2016-06-10T09:25:56Z","timestamp":1465550756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Phytanic acid activates NADPH oxidase through transactivation of epidermal growth factor receptor in vascular smooth muscle cells"],"prefix":"10.1186","volume":"15","author":[{"given":"Gursev S.","family":"Dhaunsi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayra","family":"Alsaeid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saghir","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,10]]},"reference":[{"key":"273_CR1","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1007\/s00018-005-5463-y","volume":"63","author":"DM Van den Brink","year":"2006","unstructured":"Van den Brink DM, Wanders RJ. Phytanic acid: production from phytol, its breakdown and role in human disease. Cell Mol Life Sci. 2006;63:1752\u201365.","journal-title":"Cell Mol Life Sci"},{"key":"273_CR2","first-page":"498","volume":"2011","author":"RJ Wanders","year":"1811","unstructured":"Wanders RJ, Komen J, Ferdinandusse S. Phytanic acid metabolism in health and disease. Biochim Biophys Acta. 1811;2011:498\u2013507.","journal-title":"Biochim Biophys Acta"},{"key":"273_CR3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1749-6632.2009.05254.x","volume":"1190","author":"LI Hellgren","year":"2010","unstructured":"Hellgren LI. Phytanic acid-an overlooked fatty acid in dairy fat? Ann N Y Acad Sci. 2010;1190:42\u20139.","journal-title":"Ann N Y Acad Sci"},{"key":"273_CR4","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1042\/BST0350881","volume":"35","author":"AS Wierzbicki","year":"2007","unstructured":"Wierzbicki AS. Peroxisomal disorders affecting phytanic acid alph-oxidation: a review. Biochem Soc Trans. 2007;35:881\u20136.","journal-title":"Biochem Soc Trans"},{"key":"273_CR5","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1194\/jlr.R005959","volume":"51","author":"PP Van Veldhoven","year":"2010","unstructured":"Van Veldhoven PP. Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism. J Lipid Res. 2010;51:2863\u201395.","journal-title":"J Lipid Res"},{"key":"273_CR6","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/ejhg.2008.252","volume":"17","author":"C Krause","year":"2009","unstructured":"Krause C, Rosewich H, Gartner J. Rational diagnostic strategy for Zellweger syndrome spectrum patients. Eur J Hum Genet. 2009;17:741\u20138.","journal-title":"Eur J Hum Genet"},{"key":"273_CR7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ymgme.2004.06.011","volume":"83","author":"AS Wierzbicki","year":"2004","unstructured":"Wierzbicki AS. Clinical significance of oxidation from phytol to phytanic acid in man. Mol Genet Metab. 2004;83:347.","journal-title":"Mol Genet Metab"},{"key":"273_CR8","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/jnen\/60.11.1021","volume":"60","author":"RJ Wanders","year":"2001","unstructured":"Wanders RJ, Jansen GA, Skjeldal OH. Refsum disease, peroxisomes and phytanic acid oxidation: a review. J Neuropathol Exp Neurol. 2001;60:1021\u201331.","journal-title":"J Neuropathol Exp Neurol"},{"key":"273_CR9","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.bbabio.2007.04.005","volume":"1767","author":"P Schonfeld","year":"2007","unstructured":"Schonfeld P, Wojtczak L. Fatty acids decrease mitochondrial generation of reactive oxygen species at the reverse electron transport but increase it at the forward transport. Biochim Biophys Acta. 2007;1767:1032\u201340.","journal-title":"Biochim Biophys Acta"},{"key":"273_CR10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10863-012-9491-7","volume":"45","author":"EN Busanello","year":"2013","unstructured":"Busanello EN, Zanatta A, Tonin AM, Viegas CM, Vargas CR, Leipnitz G, Ribeiro CA, Wajner M. Marked inhibition of Na+, K (+)-ATPase activity and the respiratory chain by phytanic acid in cerebellum from young rats: possible underlying mechanisms of cerebellar ataxia in Refsum disease. J Bioenerg Biomembr. 2013;45:137\u201344.","journal-title":"J Bioenerg Biomembr"},{"key":"273_CR11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1475-2891-13-17","volume":"13","author":"B Grygiel_Gorniak","year":"2014","unstructured":"Grygiel_Gorniak B. Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications\u2013a review. Nutr J. 2014;13:17.","journal-title":"Nutr J"},{"key":"273_CR12","doi-asserted-by":"crossref","first-page":"49319","DOI":"10.1074\/jbc.M204639200","volume":"277","author":"S Idel","year":"2002","unstructured":"Idel S, Ellinghaus P, Wolfrum C, Nofer JR, Gloerich J, Assmann G, Spener F, Seedorf U. Branched chain fatty acids induce nitric oxide-dependent apoptosis in vascular smooth muscle cells. J Biol Chem. 2002;277:49319\u201325.","journal-title":"J Biol Chem"},{"key":"273_CR13","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/jcp.55.8.561","volume":"55","author":"L Van Heerebeek","year":"2002","unstructured":"Van Heerebeek L, Meischi C, Stooker W, Meijer CJ, Niessen HW, Ross D. NADPH oxidase (s): new source (s) of reactive oxygen species in the vascular system. J Clin Pathol. 2002;55:561\u20138.","journal-title":"J Clin Pathol"},{"key":"273_CR14","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1046\/j.1440-1681.2003.03929.x","volume":"30","author":"SH Bengtsson","year":"2003","unstructured":"Bengtsson SH, Gulluyan LM, Dusting GJ, Drummond GR. Novel isoforms of NADPH oxidase in vascular physiology and pathophysiology. Clin Exp Pharmacol Physiol. 2003;30:860\u20136.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"273_CR15","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1042\/BST0360920","volume":"36","author":"C Guichard","year":"2008","unstructured":"Guichard C, Moreau R, Pessayre D, Epperson TK, Krause KH. NOX family NADPH oxidases in liver and in pancreatic islets: a role in the metabolic syndrome and diabetes? Biochem Soc Trans. 2008;36:920\u20139.","journal-title":"Biochem Soc Trans"},{"key":"273_CR16","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/MNH.0b013e32832923c3","volume":"18","author":"M Sedeek","year":"2009","unstructured":"Sedeek M, Hebert RL, Kennedy CR, Burns KD, Touyz RM. Molecular mechanisms of hypertension: role of Nox family NADPH oxidases. Curr Opin Nephrol Hyperten. 2009;18:122\u20137.","journal-title":"Curr Opin Nephrol Hyperten"},{"key":"273_CR17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2217\/14796678.5.1.83","volume":"5","author":"F Violi","year":"2009","unstructured":"Violi F, Basili S, Nigro C, Pignatelli P. Role of NADPH oxidase in atherosclerosis. Future Cardiol. 2009;5:83\u201392.","journal-title":"Future Cardiol"},{"key":"273_CR18","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1172\/JCI200111927","volume":"108","author":"PA Barry-Lane","year":"2001","unstructured":"Barry-Lane PA, Patterson C, van der Merwe M, Hu Z, Holland SM, Yeh ET, Runge MS. p47phox is required for atherosclerotic lesion progression in ApoE (\u2212\/\u2212) mice. J Clin Invest. 2001;108:1513\u201322.","journal-title":"J Clin Invest"},{"key":"273_CR19","doi-asserted-by":"crossref","first-page":"H1933","DOI":"10.1152\/ajpheart.00690.2005","volume":"290","author":"M Weaver","year":"2006","unstructured":"Weaver M, Liu J, Pimentel D, Reddy DJ, Harding P, Peterson EL, Pagano PJ. Adventitial delivery of dominant-negative p67phox attenuates neointimal hyperplasia of the rat carotic artery. Am J Physiol Heart Circ Physiol. 2006;290:H1933\u201341.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"273_CR20","doi-asserted-by":"crossref","first-page":"21323","DOI":"10.1074\/jbc.M110.109157","volume":"285","author":"M Herrera","year":"2010","unstructured":"Herrera M, Silva GB, Garvin JL. Angiotensin II stimulates thicj ascending limb superoxide production via protein kinase c (\u03b1)-dependent NADPH oxidase activation. J Biol Chem. 2010;285:21323\u20138.","journal-title":"J Biol Chem"},{"key":"273_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10059-010-0105-0","volume":"30","author":"MJ Morgan","year":"2010","unstructured":"Morgan MJ, Liu ZG. Reactive oxygen species in TNF alpha-induced signaling and cell death. Mol Cells. 2010;30:1\u201312.","journal-title":"Mol Cells"},{"key":"273_CR22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1096\/fj.01-1036fje","volume":"17","author":"J Kreuzer","year":"2003","unstructured":"Kreuzer J, Viedt C, Brandes RP, Seeger F, Rosemkranzz AS, Sauer H, Babich A, Nurnberg B, Kather H, Krieger-Brauer HI. Platelet-derived growth factor activates production of reactive oxygen species by NAD (P) H oxidase in smooth muscle cells through Gi1,2. FASEB J. 2003;17:38\u201340.","journal-title":"FASEB J"},{"key":"273_CR23","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1742-4658.2008.06290.x","volume":"275","author":"MD Lloyd","year":"2008","unstructured":"Lloyd MD, Darley DJ, Wierzbicki AS, Threadgill MD. Alpha-methylacyl-CoA racemase.an \u201cobscure\u2019 metabolic enzyme takes center stage. FEBS J. 2008;275:1089\u2013102.","journal-title":"FEBS J"},{"key":"273_CR24","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1042\/CS20140542","volume":"128","author":"K Roy","year":"2015","unstructured":"Roy K, Wu Y, Meitzler JL, Juhasz A, Liu H, Jiang G, Lu J, Antony S, Doroshow JH. NADPH oxidases and cancer. Clin Sci. 2015;128:863\u201375.","journal-title":"Clin Sci"},{"key":"273_CR25","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/apha.12625","volume":"216","author":"V Helfinger","year":"2016","unstructured":"Helfinger V, Henke N, Harenkamp S, Walter M, Epah J, Penski C, Mittelbron M, Schroder K. The NADPH Oxidase Nox4 mediated tumor angiogenesis. Acta Physiol. 2016;216:435\u201346.","journal-title":"Acta Physiol"},{"key":"273_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2015.00283","volume":"6","author":"A Appert-Colin","year":"2015","unstructured":"Appert-Colin A, Hubert P, Cremel G, Bennasroune A. Role of ErbB receptors in cancer Cell Migration and Invasion. Frontiers Pharmacol. 2015;6:1\u201310.","journal-title":"Frontiers Pharmacol"},{"key":"273_CR27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/01.mnh.0000441152.62943.29","volume":"23","author":"B Schreier","year":"2014","unstructured":"Schreier B, Gekle M, Grossman C. Role of epidermal growth factor receptor in vascular structure and function. Curr Opin Nephrol Hypertens. 2014;23:113\u201321.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"273_CR28","doi-asserted-by":"crossref","first-page":"561","DOI":"10.4103\/0970-2113.168099","volume":"32","author":"R Kota","year":"2015","unstructured":"Kota R, Gundet S, Gullipalli M, Linga VG, Maddali LS, Digumarti R. Prevalence and outcome of epidermal growth factor mutations in non-squamous non-small cell lung cancer patients. Lung India. 2015;32:561\u20135.","journal-title":"Lung India"},{"key":"273_CR29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0008-6363(95)00148-4","volume":"31","author":"GS Dhaunsi","year":"1996","unstructured":"Dhaunsi GS, Hassid A. Atrial and C-type natriuretic peptides amplify growth factor activity in primary aortic smooth muscle cells. Cardiovasc Res. 1996;31:37\u201347.","journal-title":"Cardiovasc Res"},{"key":"273_CR30","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1161\/01.HYP.0000188980.57312.63","volume":"46","author":"JE Jalil","year":"2005","unstructured":"Jalil JE, Perez A, Ocaranza MP, Bargetto J, Galaz A, Lavandero S. Increased aortic NADPH oxidase activity in rats with genetically high angiotensin-converting enzyme levels. Hypertension. 2005;46:1362\u20137.","journal-title":"Hypertension"},{"issue":"6","key":"273_CR31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039066","volume":"7","author":"S Akhtar","year":"2012","unstructured":"Akhtar S, Yousif MH, Chandrasekhar B, Benter IF. Activation of EGFR\/ERBB2 via pathways involving ERK1\/2, P38 MAPK, AKT and FOXO enhances recovery of diabetic hearts from ischemia-reperfusion injury. PLoS One. 2012;7(6), e39066.","journal-title":"PLoS One"},{"key":"273_CR32","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjp.0704768","volume":"136","author":"M Hirafuji","year":"2002","unstructured":"Hirafuji M, Machida T, Tsunida M, Miyamoto A, Minami I. Docosahexaenoic acid potentiates interleukin-1 beta induction of nitric oxide synthase through mechanism involving p44\/42 MAPK activation in rat vascular smooth muscle cells. Br J Pharmacol. 2002;136:613\u20139.","journal-title":"Br J Pharmacol"},{"key":"273_CR33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mam.2004.09.003","volume":"26","author":"KM Naseem","year":"2005","unstructured":"Naseem KM. The role of nitric oxide in cardiovascular diseases. Mol Aspects Med. 2005;26:33\u201365.","journal-title":"Mol Aspects Med"},{"key":"273_CR34","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1751-7176.2008.06632.x","volume":"10","author":"K Bian","year":"2008","unstructured":"Bian K, Doursout MF, Murad F. Vascular system: role of nitric oxide in cardiovascular diseases. J Clin Hypertens. 2008;10:304\u201310.","journal-title":"J Clin Hypertens"},{"key":"273_CR35","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.freeradbiomed.2007.12.025","volume":"44","author":"R Ginnan","year":"2008","unstructured":"Ginnan R, Guikema BJ, Halligan KE, Singer HA, Jourd\u2019heuil D. Regulation of smooth muscle by inducible nitric oxide synthase and NADPH oxidase in vascular proliferative diseases. Free Radic Biol Med. 2008;44:1232\u201345.","journal-title":"Free Radic Biol Med"},{"key":"273_CR36","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1096\/fj.01-0570com","volume":"16","author":"G Nickenig","year":"2002","unstructured":"Nickenig G, Baudler S, Muller C, Werner C, Werner N, Welzel H, Strehlow K, Bohm M. Redox-sensitive vascular smooth muscle cell proliferation is mediated by GKLF and Id3 in vitro and in vivo. FASEB J. 2002;16:1077\u201386.","journal-title":"FASEB J"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-016-0273-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T10:19:28Z","timestamp":1568024368000},"score":1,"resource":{"primary":{"URL":"http:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-016-0273-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,10]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["273"],"URL":"https:\/\/doi.org\/10.1186\/s12944-016-0273-9","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,10]]},"article-number":"105"}}